Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Joerg Moeller

- PMLiVE

Nexavar cleared for thyroid cancer by FDA

Bayer and Onyx win expansion of oncology drug’s use in US

Bayer symbol

EU approval for Bayer’s prostate cancer drug

Xofigo wins marketing authorisation from European Commission

Shire Basingstoke

Shire snaps up Viropharma to build $2bn rare disease unit

Gains access to Cinryze in expensive but 'strategically sound' deal

Bayer symbol

Bayer files Eylea for diabetes complication in EU

Looks to keep with Novartis’ Lucentis

Shire Basingstoke

Shire mulls UK job cuts

Enters “employee consultation process” for research site in Basingstoke

Bayer symbol

Bayer buoyant as new products drive pharma

Xarelto, Stivarga, Eylea and Xofigo all perform will in third quarter

Shire appoints finance-focused board member

Dominic Blakemore is group finance director of Compass Group

- PMLiVE

Bayer gets US nod for first-in-class Adempas

FDA clears drug for use in pulmonary artery hypertension

Bayer symbol

Bayer expects five drugs to enter phase III in 2015

Hopes to follow success of recent launches

- PMLiVE

Pfizer’s Brandicourt joins Bayer Healthcare as CEO

He replaces acting chief executive Wolfgang Plischke

Roche - Basel

Roche’s Kadcyla and Bayer’s Xofigo near EU approval

Cancer drugs receive CHMP backing

Bayer symbol

Bayer plans Russian expansion

Eyes growing demand from country's rising middle class

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links